Effects of gadolinium-based magnetic resonance imaging contrast media on red blood cells and K562 cancer cells
Open Access
- 5 September 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Trace Elements in Medicine and Biology
- Vol. 62, 126640
- https://doi.org/10.1016/j.jtemb.2020.126640
Abstract
No abstract availableKeywords
Funding Information
- Chiang Mai University
- Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University
This publication has 24 references indexed in Scilit:
- Gadolinium chloride promotes proliferation of HEK293 human embryonic kidney cells by activating EGFR/PI3K/Akt and MAPK pathwaysBioMetals, 2019
- Gadolinium-based contrast agents: Stimulators of myeloid-induced renal fibrosis and major metabolic disruptorsToxicology and Applied Pharmacology, 2019
- Gadolinium-based contrast agent toxicity: a review of known and proposed mechanismsBioMetals, 2016
- Parallel Comparative Studies on Mouse Toxicity of Oxide Nanoparticle- and Gadolinium-Based T1 MRI Contrast AgentsACS Nano, 2015
- Gadolinium induced recurrent acute pancreatitisPancreatology, 2013
- MRI contrast agents: Basic chemistry and safetyJournal of Magnetic Resonance Imaging, 2012
- Persistence of Gadolinium Contrast Enhancement in CSF: A Possible Harbinger of Gadolinium Neurotoxicity?: Fig 1.American Journal of Neuroradiology, 2008
- Cytotoxicity of Iodinated and Gadolinium-based Contrast Agents in Renal Tubular Cells at Angiographic Concentrations: In Vitro StudyRadiology, 2007
- Are Gadolinium-Based Contrast Media Nephrotoxic?: A Renal Biopsy StudyArchives of Pathology & Laboratory Medicine, 2006
- Gadolinium contrast media are more nephrotoxic than iodine media. The importance of osmolality in direct renal artery injectionsEuropean Radiology, 2006